Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapy

This publication has 14 references indexed in Scilit:

• Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled study
  Journal of the American College of Cardiology, 1991
• Reduction of infarct size estimated enzymatically in patients with acute myocardial infarction after treatment with recombinant tissue type plasminogen activator or after spontaneous coronary recanalisation: A randomised, placebo controlled study
  Fibrinolysis, 1990
• Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.
  Circulation, 1989
• Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
  Circulation, 1989
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• On the Usefulness of Fibrinolysis Variables in the Characterization of a Risk Group for Myocardial Reinfarction
  Acta Medica Scandinavica, 1987
• Role of the Contact System in Fibrinolysis
  Seminars in Thrombosis and Hemostasis, 1987
• Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones
  Thrombosis Research, 1984
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.
  Circulation, 1979
• D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombin
  Thrombosis Research, 1979